Precision Biotherapeutics: A New Era in Personalized Medicine
Precision Biotherapeutics: A New Era in Personalized Medicine
Precision biotherapeutics refers to a specialized approach within precision medicine that focuses on developing biological therapies tailored to an individual’s unique genetic makeup. These therapies are designed to target specific biological pathways or disease mechanisms and aims to transform modern medicine by providing highly personalized treatments that target the root causes of these diseases. It withholds a lot of potential to dramatically improve the effectiveness of treatments while reducing side effects.
In traditional medicine, treatments often follow a “one-size-fits-all” model, where the same medications are prescribed to all patients with a certain condition. But that leads to suboptimal outcomes, with treatments that are either ineffective or cause harmful side effects. But with advancements in genomics, proteomics, and biotechnology, precision medication is now a possibility. One of the major breakthroughs was the completion of the Human Genome Project in 2003. For the first time, scientists had a detailed map of the human genome, which provided the foundation for understanding how genetic variations contribute to diseases. At the same time, biotechnology was evolving rapidly. Scientists began developing biologics from living cells which were unlike traditional small-molecule drugs. Advances with complex techniques like CRISPR and Gene-editing, took precision medicine to newer heights.
Manognya Patnaik
University/College name : Kalinga Institute of Industrial Technology, School of Biotechnology